Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Pharmaceuticals

Jobs Axed At Boehringer Ingelheim

by Rick Mullin
August 26, 2013 | A version of this story appeared in Volume 91, Issue 34

Boehringer Ingelheim will cease some production activities at its Ben Venue plant in Bedford, Ohio, and close its Petersburg, Va., plant by the end of the year. About 400 jobs will be cut at the Bedford plant with the closure of its aseptic filling operations, along with 240 jobs at the Petersburg plant, which makes active pharmaceutical ingredients. Boehringer said an assessment of its worldwide active pharmaceutical ingredient production indicated it had too much capacity. The Bedford plant, one of the company’s oldest, has a history of manufacturing problems and several product recalls. About 800 people will continue to work at Bedford.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.